Natura-One Krill Oil Complex
Natural health product licensed in Canada
- Other names
- Natura-One Cognitive Support for Children
- Licence holder
- Pharm Canada Inc.
- NPN or DIN-HM
- 80083503
- Status
- Inactive licence
- Licence date
- 1 March 2018
- Revision date
- Not provided
- Form
- Capsule, molle
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 12.5 µg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitamine B6 Source : Pyridoxamine | 1 mg | 1,000 µg |
| Vitamine K1 Source : Vitamine K1 | 75 mcg | 75 µg |
| Phosphatidylsérine Source : Lécithine de soja enrichie en phosphatidylsérine | 50 mg | Not calculated |
| Zinc Source : Ascorbate de zinc | 3 mg | 3,000 µg |
| Huile de poisson Source : Poisson d'huile de poisson - en entier Potency : 50 mg Eicosapentaenoic acid | Not specified | Not calculated |
| Vitamine C Source : Acide ascorbique | 100 mg | 100,000 µg |
| Huile de krill Source : Euphausia pacifica - entier | 125 mg | Not calculated |
| Huile de poisson Source : Poisson d'huile de poisson - en entier Potency : 100 mg Docosahexaenoic acid | 150 mg | Not calculated |
| Vitamine A Source : Rétinol tous trans Potency : 1,250 UI | 375 mcg EAR | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 500 UI | 12.5 mcg | 12.5 µg |
| Vitamine E Source : Acétate de d-alpha tocophéryle Potency : 50 UI | 33.5 mg AT | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps to support cognitive health and brain function. Helps to support cognitive function. Source of omega-3 fatty acids for the maintenance of good health. Source of vitamins and mineral, a factor in the maintenance of good health. Helps in the maintenance of bones. Helps to prevent vitamin K deficiency. Source of antioxidants that help fight against the oxidative damage caused by free radicals.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80083503
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.